Literature DB >> 3136065

Studies of the inhibin family of hormones: a review.

C Rivier1, W Vale, J Rivier.   

Abstract

While the concept of a nonsteroidal entity of gonadal origin, which specifically regulates FSH secretion, was proposed over 50 years ago, problems linked to the assay, isolation and characterization of this protein have only recently been solved. The structure of inhibin from follicular fluid origin has been established as a heterodimer consisting of two subunits (alpha and beta) linked by disulfide bridges. The development of antisera specifically directed against the N-terminus part of the alpha-chain of inhibin has allowed the measurement of plasma levels of inhibin, as well as the evaluation of the biological effect of removal of endogenous inhibin. These studies have demonstrated age-related changes in the circulating levels of inhibin in the female rat and support the hypothesis that inhibin represents an important modulator of FSH secretion in this species.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3136065     DOI: 10.1159/000180934

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  3 in total

1.  Inhibin α-subunit N terminus interacts with activin type IB receptor to disrupt activin signaling.

Authors:  Jie Zhu; S Jack Lin; Chao Zou; Yogeshwar Makanji; Theodore S Jardetzky; Teresa K Woodruff
Journal:  J Biol Chem       Date:  2012-01-20       Impact factor: 5.157

2.  Phylogenomic analyses reveal the evolutionary origin of the inhibin alpha-subunit, a unique TGFbeta superfamily antagonist.

Authors:  Jie Zhu; Edward L Braun; Satomi Kohno; Monica Antenos; Eugene Y Xu; Robert W Cook; S Jack Lin; Brandon C Moore; Louis J Guillette; Theodore S Jardetzky; Teresa K Woodruff
Journal:  PLoS One       Date:  2010-03-04       Impact factor: 3.240

3.  Activin-A signaling promotes epithelial-mesenchymal transition, invasion, and metastatic growth of breast cancer.

Authors:  Mohsin Bashir; Surekha Damineni; Geetashree Mukherjee; Paturu Kondaiah
Journal:  NPJ Breast Cancer       Date:  2015-08-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.